HF 978: Relating to the production and administration of psilocybin, and providing penalties

What it does

This bill relates to the production of psilocybin and administration of psilocybin to persons with post-traumatic stress disorder. The bill requires a psilocybin production establishment or a qualified therapy provider location, defined in the bill, to include an inventory control system that tracks psilocybin product, defined in the bill, in real time; maintains access records; and includes a video recording system. The bill requires a psilocybin production establishment or qualified therapy provider location to allow the department of health and human services (department) to access the inventory control system at any time.

Senate subcommittee · named March 30, 2026

• Sen. Jeff Taylor (R) · jeff.taylor@legis.iowa.gov
• Sen. Herman C. Quirmbach (D) · herman.quirmbach@legis.iowa.gov
• Sen. Jeff Reichman (R) · jeff.reichman@legis.iowa.gov

Lobbying · 2 for, 3 against

For: ALEC Action; Personal Interest-Marc Beltrame

Against: Iowa Behavioral Health Association (IBHA); Iowa County Attorneys Association; Iowa Medical Society

In plain words

1. March 27, 2025Filed in the House
2. April 21, 2025Cost estimate (fiscal note) posted
3. April 21, 2025Passed the House, 84–6
4. April 22, 2025Arrived in the Senate
5. April 23, 2025Senate subcommittee named: Dawson, Bisignano and Driscoll
6. May 6, 2025Cost estimate (fiscal note) posted
7. January 14, 2026Sent to the Senate Health and Human Services committee
8. January 21, 2026Senate subcommittee named: Guth, Donahue and Salmon
9. March 18, 2026Subcommittee recommended passing it with changes
10. March 19, 2026Approved by the Senate committee
11. March 23, 2026Sent to the Senate Ways and Means committee
12. March 30, 2026Senate subcommittee named: Taylor, Quirmbach and Reichman
13. April 1, 2026Subcommittee recommended passing it with changes
14. May 1, 2026Approved by the Senate committee